Metraipolis › archive › dc_bb68ccdf316e

Evaluating the combined efficacy of Telisotuzumab Vedotin and artificial intelligence in the treatment of non-squamous non-small cell lung cancer: a narrative… — Europe PMC PMID:41189945

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41189945
DOI: 10.3389/fonc.2025.1673586
License (as archived): solo-consultazione
Archived: 2026-11-09T05:06:06.286Z
SHA-256 of the archived text: 9c5c620b95fe30b49364332d6d1e4f86e7d5ed8df43de5347e3610d2169882d4
Stable URL of this page: https://metraipolis.com/documento/dc_bb68ccdf316e

How to cite

Evaluating the combined efficacy of Telisotuzumab Vedotin and artificial intelligence in the treatment of non-squamous non-small cell lung cancer: a narrative… — Europe PMC PMID:41189945 — Europe PMC (en), https://europepmc.org/article/MED/41189945 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb68ccdf316e (Metraipolis archive dc_bb68ccdf316e, sha256 9c5c620b95fe30b49364332d6d1e4f86e7d5ed8df43de5347e3610d2169882d4)

BibTeX

@misc{dcbb68ccdf316e,
  title = {Evaluating the combined efficacy of Telisotuzumab Vedotin and artificial intelligence in the treatment of non-squamous non-small cell lung cancer: a narrative… — Europe PMC PMID:41189945},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41189945},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb68ccdf316e; sha256 9c5c620b95fe30b49364332d6d1e4f86e7d5ed8df43de5347e3610d2169882d4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41189945. Agents can read the archived copy with the MCP tool read_document.